United Therapeutics Corporation (UTHR)
NASDAQ·Healthcare·Biotechnology
$517.99
+0.36%
Mkt Cap $21.92B
Analyst Ratings
Buy
12
Hold
6
Sell
0
Price Target (38 analysts)
$636.83
Range $516.00 – $735.00
Implied Upside
+22.9%
Consensus $636.83 vs current $517.99